EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Isavuconazole utilization in a Spanish tertiary hospital

Teresa López-Cuesta, Gina Mejía-Abril, Guillermo Fernández-Jimenez, Francisco Abad-Santos

Revista Iberoamericana de Micología · 2026

DOI: 10.1016/j.riam.2026.06.004 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Revista Iberoamericana de Micología, 2026. Verfasst von Teresa López-Cuesta und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid, Madrid, Spain. Electronic address: teresa.lopezc00@gmail.c…. Hauptthemen laut MEDLINE: Triazoles, Nitriles, Pyridines, Antifungal Agents. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Invasive fungal infections pose a clinical challenge due to their high morbidity and mortality. Since its introduction in 2016, isavuconazole has emerged as a new therapeutic option, highlighting the need to evaluate its use in real-world clinical practice. AIMS: The aim of this study was to evaluate the appropriateness of isavuconazole prescription in accordance with its drug label and the pharmacotherapeutic guidelines of Hospital Universitario de La Princesa, as well as to characterize the patient population receiving this treatment. METHODS: This was a retrospective observational study of prescription-indication. All patients who received isavuconazole during hospitalization between January 2019 and June 2023 were included. Data were obtained by reviewing electronic medical records. RESULTS: A total of 129 patients were assessed, with 63.3% of these patients being male and a median age 63. Seventy seven percent suffered from malignant haematological diseases and 10.9% had been diagnosed with COVID-19 pneumonia with no other risk factor for invasive fungal infection. The percentage of inappropriate prescriptions was 22.5% (95% confidence interval: 15.2-29.8%). The main reasons for inappropriateness were prophylactic use (10.9%) and treatment of a non-indicated pathogen (4.7%). The frequency of prescription followed an upward trend, although goodness-of-fit to a linear regression model was low. CONCLUSIONS: The level of inappropriateness observed (15-30%) is relatively low compared to other studies on antifungal use, and the frequency of prescription does not exhibit a significant increase over the years. Although adherence to local and international prescribing guidelines remains suboptimal, these data demonstrate a relatively effective integration of isavuconazole into the hospital's therapeutic repertoire.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriazolesNitrilesPyridinesAntifungal AgentsInvasive Fungal InfectionsInappropriate PrescribingHumansRetrospective StudiesSpainMaleTertiary Care CentersFemaleMiddle AgedAgedDrug Utilization

Stichwörter der Autor:innen

AntifungalsAntifúngicosAppropriate prescriptionDrug utilizationInfección fúngica invasivaInvasive fungal infectionIsavuconazolIsavuconazolePrescripción adecuadaUtilización de medicamentos

Substanzen

isavuconazoleTriazolesNitrilesPyridinesAntifungal Agents

Autor:innen und Institutionen

  • School of Medicine, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid, Madrid, Spain. Electronic address: teresa.lopezc00@gmail.com.
  • Clinical Pharmacology Department, Hospital Universitario de La Princesa, School of Medicine, Universidad Autónoma de Madrid, Instituto de Investigación Sanitaria La Princesa (IIS-Princesa), Madrid, Spain.
  • Clinical Assistance Information Unit, Admission and Clinical Documentation Service, Hospital Universitario de La Princesa, Madrid, Spain.
  • School of Medicine, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid, Madrid, Spain; Clinical Pharmacology Department, Hospital Universitario de La Princesa, School of Medicine, Universidad Autónoma…

Zitieren

APA

López-Cuesta, T., Mejía-Abril, G., Fernández-Jimenez, G., & Abad-Santos, F. (2026). Isavuconazole utilization in a Spanish tertiary hospital. Revista Iberoamericana de Micología. https://doi.org/10.1016/j.riam.2026.06.004

Vancouver

López-Cuesta T, Mejía-Abril G, Fernández-Jimenez G, Abad-Santos F. Isavuconazole utilization in a Spanish tertiary hospital. Revista Iberoamericana de Micología. 2026. doi:10.1016/j.riam.2026.06.004

BibTeX
@article{LpezCuesta2026,
  author = {López-Cuesta, Teresa and Mejía-Abril, Gina and Fernández-Jimenez, Guillermo and Abad-Santos, Francisco},
  title = {Isavuconazole utilization in a Spanish tertiary hospital},
  journal = {Revista Iberoamericana de Micología},
  year = {2026},
  doi = {10.1016/j.riam.2026.06.004}
}
Kostenlos starten →